Reference is made to our stock exchange notice 21 August 2018 and release of our Second Quarter and First Half results 2018 report, we are pleased to release the attached Responsibility Statement. This is also available at our web site https://www.bergenbio.com/investors/reports/.
Contact
Rune Skeie, CFO, BerGenBio ASA
rune.skeie@bergenbio.com
+47 917 86 513
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.